Tomoko Higuchi
Nishinomiya-hama, 6638501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: October 29, 2025
Cosmetic outcomes of rotation flap and suture scaffold for breast-conserving therapy in the lower quadrants.
Journal: Breast cancer (Tokyo, Japan)
Published: July 23, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan.
Journal: International journal of clinical oncology
Published: January 10, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy.
Journal: Anticancer research
Published: January 05, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: November 04, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
Journal: International journal of clinical oncology
Published: July 14, 2024
Relationship between FDG-PET and the immune microenvironment in breast cancer.
Journal: European journal of radiology
Published: September 03, 2022
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Journal: Anticancer research
Published: July 24, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Journal: Anticancer research
Published: July 23, 2022
Early assessment of tumor response using 18F-FDG PET/CT after one cycle of systemic therapy in patients with recurrent and metastatic breast cancer.
Journal: Hellenic journal of nuclear medicine
Published: June 01, 2022
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Journal: Anticancer research
Published: March 25, 2020
Last Updated: 09/26/2026